NALOXONE HYDROCHLORIDE (Page 4 of 4)

HOW SUPPLIED

1 mg/mL naloxone hydrochloride injection USP, for intravenous, intramuscular and subcutaneous administration.

Available as follows:

1 mg/mL

2 mL single dose disposable prefilled syringes, in the MIN-I-JET® system with 21 G. x 11/2” needle. Shrink Wrapped Packages of 10.

NDC 76329-1469-1 Stock No. 1469 (contains no preservative)

2 mL single dose disposable Luer-JetTM Luer-Lock Prefilled Syringe. Shrink Wrapped Packages of 10.

NDC 76329-3369-1 Stock No. 3369 (contains no preservative)

Syringe Assembly Directions:

The MIN-I-JET® syringe with needle, illustrated below, is the basic unit upon which all the other syringe systems are built; slight adaptations and/ or additional auxiliary parts create the other syringe systems. Assembly directions remain essentially the same.

USE ASEPTIC TECHNIQUE

Do not assemble until ready to use.

//medlibrary.org/lib/images-rx/naloxone-hydrochloride-16/image1-300x122.jpg
(click image for full-size original)

SPL UNCLASSIFIED

Store at 25˚C (77˚F); excursions permitted to 15˚-30˚C (59˚-86˚F). [See USP Controlled Room Temperature.]
Protect from light.
Store in carton until contents have been used.

INTERNATIONAL MEDICATION SYSTEMS, LIMITEDSO. EL MONTE, CA 91733, U.S.A. REV. 11-13

An Amphastar Pharmaceuticals Company

© INTERNATIONAL MEDICATION SYSTEMS, LIMITED 2013

SAMPLE PACKAGE LABEL

//medlibrary.org/lib/images-rx/naloxone-hydrochloride-16/label1-300x274.jpg
(click image for full-size original)

NALOXONE HYDROCHLORIDE naloxone hydrochloride injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:52584-978(NDC:76329-1469)
Route of Administration PARENTERAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
NALOXONE HYDROCHLORIDE (NALOXONE) NALOXONE HYDROCHLORIDE 1 mg in 1 mL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:52584-978-01 1 BOX in 1 BAG contains a BOX
1 1 SYRINGE in 1 BOX This package is contained within the BAG (52584-978-01) and contains a SYRINGE
1 2 mL in 1 SYRINGE This package is contained within a BOX and a BAG (52584-978-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA072076 12/06/2013
Labeler — General Injectables & Vaccines, Inc (108250663)

Revised: 11/2021 General Injectables & Vaccines, Inc

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.